A research team has found many new cancer genes - expanding the list of known genes tied to these cancers by 25 percent. Moreover the study shows that many key cancer genes still remain to be discovered. The Broad Institute-led research team’s work which lays a critical foundation for future cancer drug development also shows that creating a comprehensive catalog of cancer genes for scores of cancer types is feasible with as few as 100000 patient samples. Broad Institute founding director Eric Lander senior co-author said that the knowledge of genes and their pathways will highlight new potential drug targets
